An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.
This study has been completed.
First Posted: October 16, 2009
Last Update Posted: June 22, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 4, 2010|
|Primary Completion Date:||January 4, 2010 (Final data collection date for primary outcome measure)|